APA (7th ed.) Citation

YC, C., Z, F., C, L., CJ, P., Y, L., LN, W., . . . LD, Z. (2024). miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers. Technology in cancer research & treatment, 23, 15330338241248576. https://doi.org/10.1177/15330338241248576

Chicago Style (17th ed.) Citation

YC, Cheng, et al. "MiR-133a and MiR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers." Technology in Cancer Research & Treatment 23 (2024): 15330338241248576. https://doi.org/10.1177/15330338241248576.

MLA (9th ed.) Citation

YC, Cheng, et al. "MiR-133a and MiR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers." Technology in Cancer Research & Treatment, vol. 23, 2024, p. 15330338241248576, https://doi.org/10.1177/15330338241248576.